Powell Michael

Powell Michael is listed in filings as Director at Bicara Therapeutics Inc. Common Stock. This profile follows SEC Form 4 activity through Jun 10, 2025, including 1 public disclosure. Recent filings connect the profile to Bicara Therapeutics Inc. Common Stock (BCAX). The current snapshot covers public activity from Jun 10, 2025. Reported amounts are shown as $272.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.